4.7 Review

Gut microbiota- bone axis

Journal

CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION
Volume 57, Issue 8, Pages 1664-1672

Publisher

TAYLOR & FRANCIS INC
DOI: 10.1080/10408398.2015.1010034

Keywords

Development; aging; bone mineral density; bone structure; probiotics

Funding

  1. NSERC
  2. Dairy Research Cluster Initiative (Dairy Farmers of Canada, Agriculture and Agri-Food Canada, Canadian Dairy Commission)
  3. Centrum Foundation Research Innovation Fund
  4. Department of Nutritional Sciences at the University of Toronto

Ask authors/readers for more resources

The gut microbiota (GM) is an important regulator of body homeostasis, including intestinal and extraintestinal effects. This review focuses on the GM-bone axis, which we define as the effect of the gutassociated microbial community or the molecules they synthesize, on bone health. While research in this field is limited, findings from preclinical studies support that gut microbes positively impact bone mineral density and strength parameters. Moreover, administration of beneficial bacteria (probiotics) in preclinical models has demonstrated higher bone mineralization and greater bone strength. The preferential bacterial genus that has shown these beneficial effects in bone is Lactobacillus and thus lactobacilli are among the best candidates for future clinical intervention trials. However, their effectiveness is dependent on stage of development, as early life constitutes an important time for impacting bone health, perhaps via modulation of the GM. In addition, sex-specific difference also impacts the efficacy of the probiotics. Although auspicious, many questions regarding the GM-bone axis require consideration of potential mechanisms; sex-specific efficacy; effective dose of probiotics; and timing and duration of treatment. Abbreviations: BMC: bone mineral content; BMD: bone mineral density; BV/TV%: bone volume as a percentage of total volume; CONV-D: conventionalized; CONV-R: conventionally-raised; CD: Crohn's disease; DXA: Dual-energy X-ray Absorptiometry; GF: germ-free; GIT: gastrointestinal tract; GM: gut microbiota; 5-HT: 5-hydroxytryptamine; IBD: inflammatory bowel disease; IL: interleukin; IBS: irritable bowel syndrome; LPS: lipopolysaccharide; LBP: LPS binding protein; OCL: osteoclast; OPG: osteoprotegrin; Ovx: ovariectomized; RANK: receptor activator of nuclear factor kappa-B; RANKL: receptor activator of nuclear factor kappa-B ligand; SAM: senescence accelerated mice; SERT: serotonin transporter; TLRs: toll-like receptors; Tph1: tryptophan hydroxylase-1; TNF: tumor necrosis factor; UC: ulcerative colitis

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available